News
Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, announced upcoming presentations at ...
21hon MSN
The multi-hyphenate mogul is bringing her talents and passion for travel to television with her new show, Solo Traveling, on Roku.
The Village Voice remembers the art and provocations of the underground comix genius, Vaughn Bode, on the 50th anniversary of his death.
Patients were treated with MIPLYFFA in a 48-month open-label extension (OLE) study following the Phase 2/3, randomized, double-blind, placebo-controlled pivotal trial. The OLE data demonstrate that ...
1d
India Today on MSNDesign | Sleep, rebrandedArchitects, interior designers and industry insiders share how today's homeowners want modern spaces designed for better slumber ...
You can’t scroll through Instagram without seeing yet another famous face radiating red light from an LED therapy mask. But ...
A scientific team supported in part by the National Institutes of Health (NIH) has developed a new, ultra-high-resolution ...
How do scientists monitor the populations of the threatened California red-legged frog? With careful listening and a little ...
Those cleaning up include residents evacuated to escape floodwaters; a business owner who worked to recover unique pieces and ...
The potential for these kinds of machines to reshape computer processing, increase energy efficiency, and revolutionize ...
2d
News Medical on MSNStandardized brain cell atlas to accelerate Parkinson's and Alzheimer's researchResearchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...
Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks. In 2014, Hamilton went to Liberia as part of the NPR team that covered Ebola. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results